Skip to main content

Day: December 20, 2019

Kalytera Announces Intention to Seek Amendment of Secured Convertible Debentures Due December 2019

SAN FRANCISCO and TEL AVIV, Israel, Dec. 20, 2019 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE: KLY and OTCQB: KALTF) (the “Company” or “Kalytera“) today announced that it has not paid the principal (in the amount of C$453,000) and interest (in the amount of C$19,323.96) owing on its 9% secured convertible debentures due December 20, 2019 (the “Debentures”).  The Company instead intends to seek approval from the TSX Venture Exchange (the “TSXV”) and the holders of outstanding Debentures (collectively, the “Holders”) to extend the maturity date thereof to December 20, 2020 and to reduce the conversion price of the Debentures to C$0.05 per Common Share (from C$0.13 per Common Share).There is no assurance that the amendments requested by the Company will...

Continue reading

Le Château Reports Third Quarter Results

MONTRÉAL, Dec. 20, 2019 (GLOBE NEWSWIRE) — Le Château Inc. (TSX VENTURE: CTU), today reported financial results for the third ended October 26, 2019. Unless otherwise indicated, the Company’s results for the third quarter reflect the impact of the implementation of IFRS 16, as described below under “Adoption of IFRS 16 – Leases”.Sales for the third quarter ended October 26, 2019 amounted to $42.1 million as compared with $45.1 million for the third quarter ended October 27, 2018, a decrease of 6.5%, with 12 fewer stores in operation. Comparable store sales, which include online sales, decreased 4.0% versus the same period a year ago, with comparable regular store sales decreasing 4.0% and comparable outlet store sales decreasing 3.9% (see non-GAAP measures below). Sales continue to be negatively...

Continue reading

Le Château publie ses résultats du troisième trimestre

MONTRÉAL, 20 déc. 2019 (GLOBE NEWSWIRE) — Le Château Inc. (TSX-CROISSANCE : CTU) a annoncé aujourd’hui ses résultats financiers pour le troisième trimestre clos le 26 octobre 2019. Sauf indication contraire, les résultats de la Société pour le troisième trimestre tiennent compte de l’incidence de la mise en œuvre de l’IFRS 16, qui est décrite ci-après à la rubrique « Adoption de l’IFRS 16, Contrats de location ».Le chiffre d’affaires pour le troisième trimestre clos le 26 octobre 2019 s’est élevé à 42,1 millions de dollars comparativement à 45,1 millions de dollars pour le troisième trimestre clos le 27 octobre...

Continue reading

PHOTO RELEASE—Huntington Ingalls Industries Awarded Submarine Planning Yard Contract Worth A Potential $454 Million

NEWPORT NEWS, Va., Dec. 20, 2019 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE: HII) announced today that its Newport News Shipbuilding division has been awarded a planning yard design services contract with a potential total value of $454.1 million for nuclear-powered submarines.The contract will provide planning, engineering and design, and logistics and modernization support for new, operational, conversion and decommissioning submarines. The contract includes options over a five-year period through 2024, and is initially funded at $5.3 million.“We have a proven history of executing Navy ship design, shipbuilding and maintenance work, and we continue to grow, develop and train the workforce necessary to support the increasing pace and volume of our work with the U.S. Navy,” said Charles Southall, Newport...

Continue reading

PHOTO RELEASE–Huntington Ingalls Industries Wins Planning Yard Contract Worth A Potential $453.4 Million

PASCAGOULA, Miss., Dec. 20, 2019 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE: HII) announced today that its Ingalls Shipbuilding division has been awarded a contract with a potential total value of $453.4 million for planning yard services in support of in-service Ticonderoga-class cruisers and Spruance-class destroyers. The contract includes options over a five-year period.“This is another exciting opportunity for our shipbuilders to continue our 35 years of planning yard experience,” said Ingalls Shipbuilding President Brian Cuccias. “We take pride in not only building state-of-the-art warships for the U.S. Navy, but also in caring for them while they are in active service. We look forward to utilizing our talent and resources to complete the work needed to return these cruisers to...

Continue reading

Aleafia Health Provides Update Regarding Product Shipment

TORONTO, Dec. 20, 2019 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) has received an update from a third-party transportation company (the “Carrier”) regarding a shipment of Aleafia Health’s packaged, finished cannabis products intended for the adult-use market. The authorized Carrier was in possession of the Company’s cannabis products and was contracted to deliver the shipment to provincial wholesale facilities in the next week. On December 20, 2019 the Carrier notified Aleafia Health that the transportation vehicle containing the shipment had been reported stolen from the Carrier’s facility. The third-party Carrier has filed a police report, and is cooperating with the ongoing investigation.In accordance with...

Continue reading

FTE Signs Definitive Agreement to Acquire 3,000+ Unit Rental Home Asset Owner and Operator

NEW YORK, Dec. 20, 2019 (GLOBE NEWSWIRE) — FTE Networks, Inc. (NYSE American: FTNW) (“FTE” or the “Company”), announced that it has signed a definitive agreement to acquire the assets of Vision Property Management LLC (“Vision”) and its affiliated assets which include more than 3,000 residential real estate assets in 46 states.Vision’s management team assembled its portfolio of houses over the past 10 years and will continue as senior executives of the Company and major shareholders. They will develop their strategy to acquire and build affordable housing properties for sale or for rent. FTE has assumed approximately $80MM in debt held by Vision, which it plans to refinance into a new lower cost credit facility including additional renovation capital allowing for the ability to capture additional...

Continue reading

Les Thés DAVIDsTEA annonce ses résultats financiers du troisième trimestre de l’exercice 2019

Perte d’exploitation de 9,3 M$ comparativement à une perte de 10,7 M$BAIIA1 négatif de 4,5 M$ comparativement à un BAIIA négatif de 8,6 M$Hausse de 14,1 % ou 1,1 M$ des ventes tirées du commerce de gros et du commerce électroniqueFlux de trésorerie positifs liés à l’exploitation de 4,8 M$ comparativement à des flux de trésorerie négatifs de 18,0 M$Trésorerie nette de 28,0 M$MONTRÉAL, 20 déc. 2019 (GLOBE NEWSWIRE) — Les Thés DAVIDsTEA Inc. (Nasdaq: DTEA), l’un des premiers marchands de thé en Amérique du Nord, annonce ses résultats du troisième trimestre pour la période close le 2 novembre 2019 (l’ « exercice 2019 »). Sauf indication contraire,...

Continue reading

Fairfax Africa Completes $80 Million Revolving Credit Facility

TORONTO, Dec. 20, 2019 (GLOBE NEWSWIRE) — NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES(Note: All dollar amounts in this news release are expressed in U.S. dollars, except as otherwise noted).Fairfax Africa Holdings Corporation (“Fairfax Africa”) (TSX: FAH.U) is pleased to announce that it has completed an $80 million secured revolving demand credit facility with a syndicate of Canadian lenders.Fairfax Africa is an investment holding company whose objective is to achieve long-term capital appreciation, while preserving capital, by investing in public and private equity securities and debt instruments in Africa and African businesses or other businesses with customers, suppliers or business primarily conducted in, or dependent on, Africa.For further information, contact:                   Keir...

Continue reading

Curetis Receives U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens

 Broad Unyvero LRT BAL panel also includes atypical pathogens such as Pneumocystis jiroveciiClearance expected to substantially increase total addressable market for Unyvero System in the U.S.Commercial launch in the U.S. expected for Q1-2020Amsterdam, the Netherlands, Holzgerlingen, Germany, and San Diego, CA, USA, December 20, 2019, 23:30 CET — Curetis N.V. (the “Company” and, together with its subsidiaries, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that the Company has received 510(k) clearance by the U.S. Food and Drug Administration (FDA) to market its Unyvero LRT Lower Respiratory Tract Application Cartridge for use with bronchoalveolar lavage (BAL) samples to diagnose lower respiratory tract infections such as pneumonia. The LRT BAL panel detects a broad...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.